WHO Consults On Draft Q&As To Support 2009 Guide On Evaluation Of Biosimilars
Executive Summary
The Q&A document covers a wide a range of issues, ranging from licensing requirements to pharmacovigilance. However, it does not address interchangeability, switching, substitution, naming and shortages.
You may also be interested in...
Long-Awaited EU Clinical Trials Portal Meets Major Milestone
A simplified process for registering and evaluating clinical trials promised by the EU Clinical Trial Regulation is finally set to become a reality.
ICH Drafts Modernized Principles For E6 Good Clinical Practice Guide
As part of efforts to “renovate” its good clinical practice (GCP) framework, the International Council for Harmonisation has framed new overarching GCP principles that can be applied to diverse trial types and data sources.
Global Inspection Body To Check Value Of Exchanging Data On ‘Borderline Compliance’ Cases
The 2021 work plan of PIC/S, the international group of pharmaceutical inspectorates, includes renewed efforts to carry out projects that could not be completed due to the coronavirus pandemic.